Deprescribing Proton Pump Inhibitors in an Academic, Primary Care Clinic Quality Improvement Project

被引:14
|
作者
Nallapeta, Naren [1 ]
Reynolds, Jessica L. [2 ]
Bakhai, Smita [3 ]
机构
[1] Univ Buffalo State Univ New York, Dept Internal Med, Buffalo, NY 14215 USA
[2] Univ Buffalo State Univ New York, Dept Med, Buffalo, NY 14215 USA
[3] Univ Buffalo State Univ New York, ECMC, Dept Internal Med, Suite 15,462 Grider St, Buffalo, NY 14215 USA
基金
美国国家卫生研究院;
关键词
proton pump inhibitors; quality improvement; evidence-based guidelines; deprescribing PPI; primary care; inappropriate use of PPI; COMMUNITY-ACQUIRED PNEUMONIA; LONG-TERM USE; RISK; THERAPY; INFECTION; BENEFITS; OVERUSE; NEED;
D O I
10.1097/MCG.0000000000001317
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Goal: The goal of this study was to reduce the percentage of inappropriately prescribed proton pump inhibitors (PPIs) in patients aged 50 and older from 80% (baseline) to 60% within 12 months in an academic, internal medicine clinic. Background: The use of PPIs has increased drastically worldwide. Internal medicine clinic patients had inappropriate use of PPIs for an average of 4 to 5 years. Study: A multidisciplinary quality improvement team used the Plan-Do-Study-Act Model of health care improvement and performed a root cause analysis to identify barriers to inappropriate use of PPIs. The outcome measure was the percentage of patients inappropriately prescribed PPI. Process measures were completion rates of PPI risk assessment and esophagogastroduodenoscopy. Interventions included the creation of customized electronic health record templates and education to providers and patients. Analysis was performed using monthly statistical process control charts. Results: The average rate of PPI discontinuation was 51.1% (n=92/180), which corresponds to 30.0% inappropriate PPI usage within 12 months. The mean PPI discontinuation rate in the 1-year prestudy, study and 6 months poststudy period was 2.0%, 32.0%, and 49.7%, respectively. The mean esophagogastroduodenoscopy completion rate was 49.8% from the baseline of Conclusions: We achieved a statistically significant and sustainable reduction of inappropriate PPI use to 30% from the baseline rates of 80% and surpassed our goal within 12 months. This quality improvement was unique as no pharmacy personnel was utilized in this process. The multifaceted strategies in a safety-net internal medicine clinic resulted in successful deprescribing of PPI and can be replicated in other setting.
引用
收藏
页码:864 / 870
页数:7
相关论文
共 50 条
  • [41] Epley's Maneuver in Primary Care: A Quality Improvement Project
    Hameed, Muhammad
    Shaheen, Shabana
    Malik, M. Imran
    Qabeel, Yousef Essam Hassan
    WORLD FAMILY MEDICINE, 2021, 19 (10): : 117 - 123
  • [42] Improving Cancer Screening Rates in Primary Care via Practice Facilitation and Academic Detailing: A Multi-PBRN Quality Improvement Project
    Morley, Christopher P.
    Schad, Laura A.
    Tumiel-Berhalter, Laurene M.
    Brady, Laura A.
    Bentham, Alexandrea
    Vitale, Karen
    Norton, Amanda
    Noronha, Gary
    Swanger, Carlos
    JOURNAL OF PATIENT-CENTERED RESEARCH AND REVIEWS, 2021, 8 (04) : 315 - 322
  • [43] Magnitude and Determinants of Long-term Use of Proton Pump Inhibitors Among Portuguese Older Adults in Primary Health Care
    Rodrigues, Daniela A.
    Herdeiro, Maria Teresa
    Mateos-Campos, Ramona
    Figueiras, Adolfo
    Roque, Fatima
    CLINICAL THERAPEUTICS, 2024, 46 (02) : e54 - e58
  • [44] Improving Access to Contraception Care at a Local Nonprofit Clinic: A Quality Improvement Project
    Croskey, Olivia
    Norris, Cecilia
    JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 2025, 27 (02) : 286 - 293
  • [45] Patient and Physician Satisfaction with Proton Pump Inhibitors (PPIs): Are There Opportunities for Improvement?
    Chey, William D.
    Mody, Reema R.
    Izat, Esin
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (12) : 3415 - 3422
  • [46] Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: A nationwide observational study
    Haastrup, Peter
    Paulsen, Maja Skov
    Zwisler, Jon Eik
    Begtrup, Luise Molenberg
    Hansen, Jane Moller
    Rasmussen, Sanne
    Jarbol, Dorte Ejg
    EUROPEAN JOURNAL OF GENERAL PRACTICE, 2014, 20 (04) : 290 - 293
  • [47] Proton pump inhibitors and mandibular bone quality: A preliminary study
    Cosgunarslan, Aykagan
    Canger, Emin Murat
    Cabuk, Damla Soydan
    DENTOMAXILLOFACIAL RADIOLOGY, 2021, 50 (06)
  • [48] Direct oral anticoagulant (DOAC) monitoring within primary care: a quality improvement project
    McFadzean, Isobel Joy
    Francis, Rhian
    Fischetti, Catrin
    Morton, Vanessa
    Goodfellow, Susan
    BMJ OPEN QUALITY, 2023, 12 (02)
  • [49] Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care
    Ahrens, D.
    Behrens, G.
    Himmel, W.
    Kochen, M. M.
    Chenot, J. -F.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (08) : 767 - 773
  • [50] Improving the feasibility of deprescribing proton pump inhibitors: GPs' insights on barriers, facilitators, and strategies
    Japelj, Nusa
    Knez, Lea
    Petek, Davorina
    Horvat, Nejc
    FRONTIERS IN PHARMACOLOGY, 2024, 15